<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-25469" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Nonviral Myocarditis</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Pandey</surname>
            <given-names>Shubhi</given-names>
          </name>
          <aff>Saint Vincent Hospital</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Rajasurya</surname>
            <given-names>Venkat</given-names>
          </name>
          <aff>SIU School of Medicine</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Shubhi Pandey declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Venkat Rajasurya declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>22</day>
          <month>5</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-25469.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Myocarditis is a significant cause of sudden death and nonischemic dilated cardiomyopathy, especially in the young. It has a very diverse and sometimes, nonspecific presentation, and can mimic various disease entities. Although viral myocarditis is the most common type, nonviral myocarditis also must be considered. Nonviral myocarditis comprises several infectious and autoimmune etiologies that should not be overlooked; recognition is critical for a timely intervention. This activity describes the etiology, evaluation, and management of nonviral myocarditis and highlights the role of interprofessional teams in improving outcomes for affected patients.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Review the etiology of nonviral myocarditis.</p></list-item><list-item><p>Outline the typical presentation of a patient with nonviral myocarditis.</p></list-item><list-item><p>Summarize the management of nonviral myocarditis.</p></list-item><list-item><p>Explain the importance of coordination amongst interprofessional team members to improve outcomes for patients with nonviral myocarditis.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=25469&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=25469">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-25469.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>German physician Joseph Friedrich&#x000a0;Sobernheim coined the term "myocarditis"&#x000a0;in 1837, which translates to "inflammation of the myocardium." However, for a long time, there was no clear consensus on what truly&#x000a0;constituted&#x000a0;myocarditis. In the nineteenth and early twentieth century,&#x000a0;the term was a catch-all diagnosis for many&#x000a0;non-valvular&#x000a0;heart diseases, including what we now recognize as hypertensive and ischemic heart diseases.<xref ref-type="bibr" rid="article-25469.r1">[1]</xref> Even after myocardial ischemia emerged as a separate and significant entity, the term "myocarditis&#x0201d;&#x000a0;was used&#x000a0;interchangeably&#x000a0;with other cardiomyopathies. The confusion partly stemmed from the diversity of its clinical manifestations, which can range anywhere from nonspecific symptoms like fever, myalgias, diminished exercise tolerance to hemodynamic collapse and sudden death. It was only in 1995 that the World Health Organization and the International Society and Federation of Cardiology classified the different cardiomyopathies and defined myocarditis as "an inflammatory disease of the myocardium, diagnosed by established histological, immunological, and immunohistochemical criteria."<xref ref-type="bibr" rid="article-25469.r2">[2]</xref> However, as the diagnosis relies on the infrequently performed endomyocardial biopsy (EMB), its actual incidence remains unknown. Myocarditis can be mild and self-limiting with minimal ventricular dysfunction, to fulminant with severe hemodynamic compromise requiring&#x000a0;inotropic agents or mechanical circulatory support. When associated with cardiac dysfunction, the term for the condition is inflammatory cardiomyopathy.<xref ref-type="bibr" rid="article-25469.r2">[2]</xref></p>
      </sec>
      <sec id="article-25469.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The cause of myocarditis is most commonly viral, and most prominently linked with enteroviruses like Coxsackie B,<xref ref-type="bibr" rid="article-25469.r3">[3]</xref> but also associated with parvovirus B19 (PVB19), adenovirus, influenza A virus, human herpesvirus (HHV), Epstein&#x02013;Barr virus, cytomegalovirus, hepatitis C virus, and HIV.<xref ref-type="bibr" rid="article-25469.r4">[4]</xref></p>
        <p>The non-viral causes of myocarditis can broadly classify into infectious, immune-mediated, and toxic.<xref ref-type="bibr" rid="article-25469.r5">[5]</xref></p>
        <p><italic toggle="yes">Infectious</italic>&#x000a0;causes include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Bacterial pathogens like group&#x000a0;A&#x000a0;<italic toggle="yes">Streptococci</italic>, which can cause rheumatic myocarditis, characterized by Aschoff nodules on histopathology;&#x000a0;<italic toggle="yes">Corynebacterium&#x000a0;diphtheriae</italic>&#x000a0;associated with toxin-mediated myocarditis;&#x000a0;<italic toggle="yes">Mycobacterium,</italic> and&#x000a0;<italic toggle="yes">Mycoplasma&#x000a0;pneumoniae</italic>. Other bacteria which may lead to myocarditis include&#x000a0;<italic toggle="yes">Staphylococcus, Gonococcus, Meningococcus, Pneumococcus, Hemophilus</italic>&#x000a0;<italic toggle="yes">influenzae</italic>, and&#x000a0;<italic toggle="yes">Brucella</italic>. There are also a few reported cases of myocarditis associated with non-typhi&#x000a0;<italic toggle="yes">Salmonella</italic>&#x000a0;species like&#x000a0;<italic toggle="yes">S. enteritidis</italic> and&#x000a0;<italic toggle="yes">S. berta</italic><italic toggle="yes">,</italic>&#x000a0;and rarely with typhoid fever<xref ref-type="bibr" rid="article-25469.r6">[6]</xref><xref ref-type="bibr" rid="article-25469.r7">[7]</xref><xref ref-type="bibr" rid="article-25469.r8">[8]</xref><xref ref-type="bibr" rid="article-25469.r9">[9]</xref></p>
          </list-item>
          <list-item>
            <p>Spirochetes like&#x000a0;<italic toggle="yes">Borrelia&#x000a0;burgdorferi</italic>, which causes Lyme myocarditis and may correlate with atrioventricular conduction abnormalities;<italic toggle="yes">&#x000a0;Leptospira</italic>, associated with Weil's disease; and rarely<italic toggle="yes">&#x000a0;Treponema pallidum</italic>, causing gummatous myocarditis in tertiary syphilis</p>
          </list-item>
          <list-item>
            <p>Protozoa like&#x000a0;<italic toggle="yes">Trypanosoma&#x000a0;cruzi</italic>, causing Chagas' disease, which could present as acute myocarditis or chronic cardiomyopathy;&#x000a0;<italic toggle="yes">Toxoplasma&#x000a0;gondii</italic>, associated with post-cardiac transplant myocarditis and rejection;&#x000a0;<italic toggle="yes">Entameba&#x000a0;histolytica</italic>, which often also causes acute pericarditis;&#x000a0;<italic toggle="yes">Leishmania</italic>; and&#x000a0;<italic toggle="yes">Naegleria fowleri</italic><xref ref-type="bibr" rid="article-25469.r10">[10]</xref></p>
          </list-item>
          <list-item>
            <p>Parasitic causes like cysticercosis because of&#x000a0;<italic toggle="yes">Tenia&#x000a0;solium</italic>;&#x000a0;<italic toggle="yes">Trichinella</italic>-associated eosinophilic myocarditis, larva migrans, and&#x000a0;<italic toggle="yes">Echinococcus&#x000a0;granulosus</italic></p>
          </list-item>
          <list-item>
            <p>Fungi like&#x000a0;<italic toggle="yes">Aspergillus, Candida, Actinomyces, Blastomyces,&#x000a0;Coccidioides,&#x000a0;Histoplasma, Cryptococcus,&#x000a0;Mucormycosis, Nocardia</italic>, and&#x000a0;<italic toggle="yes">Sporothrix</italic></p>
          </list-item>
          <list-item>
            <p>Rickettsial diseases like Q fever, caused by&#x000a0;<italic toggle="yes">Coxiella burnetii</italic>; or Rocky Mountain spotted fever,&#x000a0;due to&#x000a0;<italic toggle="yes">R.&#x000a0;rickettsii</italic></p>
          </list-item>
        </list>
        <p><italic toggle="yes">Immune-mediated</italic>&#x000a0;myocarditis could be&#x000a0;due to:</p>
        <list list-type="bullet">
          <list-item>
            <p>Autoimmune causes, like giant cell myocarditis and infection-negative lymphocytic myocarditis; or associated with immunologic syndromes like systemic lupus erythematosus, Churg-Strauss syndrome, Wegener&#x02019;s granulomatosis, rheumatoid arthritis, Kawasaki disease, inflammatory bowel disease, celiac disease, systemic sclerosis, polymyositis, myasthenia gravis, Type 1 diabetes mellitus, thyrotoxicosis or sarcoidosis</p>
          </list-item>
          <list-item>
            <p>Hypersensitivity reaction to drugs like sulfonamides, penicillin, cephalosporins, furosemide, thiazide, digoxin, dobutamine, tricyclic antidepressants, isoniazid, tetracycline, phenytoin, phenylbutazone, and methyldopa; or serum sickness-like reaction to toxoids or vaccines</p>
          </list-item>
          <list-item>
            <p>Allograft rejection after a cardiac transplant</p>
          </list-item>
        </list>
        <p><italic toggle="yes">Toxic</italic>&#x000a0;myocarditis may&#x000a0;be caused&#x000a0;by:</p>
        <list list-type="bullet">
          <list-item>
            <p>Drugs, like amphetamines, cocaine, ethanol, chemotherapeutic agents (anthracyclines, trastuzumab, cyclophosphamide), antipsychotic medications (clozapine, lithium) and interleukin-2</p>
          </list-item>
          <list-item>
            <p>Heavy metal toxicity with copper, iron, lead</p>
          </list-item>
          <list-item>
            <p>Metabolic causes like pheochromocytoma, thyrotoxicosis, hemochromatosis, or beriberi</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-25469.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Myocarditis is a significant cause of sudden death and nonischemic dilated cardiomyopathy, especially in the young. It was recently ranked as the third leading cause of sudden cardiac death in competitive athletes by the American Heart Association and&#x000a0;the American College of Cardiology, and it&#x000a0;is considered&#x000a0;the most common known cause of dilated cardiomyopathy in children less than 18 years of age.<xref ref-type="bibr" rid="article-25469.r11">[11]</xref> However, the actual burden of myocarditis is challenging to determine and is likely under-reported. Prevalence estimated from autopsy studies of young people with sudden cardiac death is highly variable ~ 2 to 42%.</p>
        <p>Whereas neonates and children are more susceptible to viral-induced fulminant myocarditis,<xref ref-type="bibr" rid="article-25469.r12">[12]</xref> acute lymphocytic and giant cell myocarditis are more commonly seen in adults with a median age of 43 years.<xref ref-type="bibr" rid="article-25469.r13">[13]</xref> Men have a slightly higher prevalence of myocarditis than females, which&#x000a0;is believed&#x000a0;to be due to the natural hormonal variations that promote a proinflammatory Th1-type immune response in men, in contrast to the FOXP3+, CTLA4+ regulatory T cell response in women.<xref ref-type="bibr" rid="article-25469.r14">[14]</xref></p>
        <p>Unlike viral myocarditis, there is a lot of variation in the distribution of non-viral pathogens causing myocarditis. Rheumatic heart disease and tertiary syphilis are rare in the developed nations because of better access to healthcare and early administration of antibiotics. Enteric pathogens and parasitic infestations are more prevalent in regions with poor sanitation, whereas&#x000a0;diphtheritic myocarditis&#x000a0;is limited&#x000a0;to populations with poor immunization coverage.</p>
        <p>Some pathogens are endemic to certain geographic regions, such as follows: <italic toggle="yes"/></p>
        <list list-type="bullet">
          <list-item>
            <p><italic toggle="yes">Borrelia&#x000a0;burgdorferi, Babesia,</italic>&#x000a0;and&#x000a0;<italic toggle="yes">Anaplasma</italic>&#x000a0;species, associated with&#x000a0;<italic toggle="yes">Ixodes</italic>&#x000a0;tick (northeastern United States)</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">Trypanosoma&#x000a0;cruzi</italic>&#x000a0;(rural areas of Central and South America)</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">Coccidioides&#x000a0;immitis</italic>&#x000a0;(the southwestern United States and northern Mexico)</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">Histoplasma&#x000a0;capsulatum</italic>&#x000a0;(central and eastern United States, most prevalent in the Ohio and Mississippi river valley</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes"> Blastomyces dermatitidis&#x000a0;</italic>(eastern North America, around St. Lawrence and Mississippi river systems)</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-25469.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Most studies&#x000a0;have focused on the pathogenesis of viral myocarditis, using murine models.&#x000a0;However, barring a few differences, most cases of myocarditis develop from the same three-step sequence of events<xref ref-type="bibr" rid="article-25469.r15">[15]</xref><xref ref-type="bibr" rid="article-25469.r16">[16]</xref>:</p>
        <list list-type="order">
          <list-item>
            <p>Acute injury because of infectious or non-infectious causes, leading to myocardial damage</p>
          </list-item>
          <list-item>
            <p>Myocytolysis&#x000a0;causing the release of intracellular antigens and cytoskeletal proteins like cardiac myosin</p>
          </list-item>
          <list-item>
            <p>Activation of the innate immune response against cardiac self-antigens, followed by CD4+ T cell activation, clonal expansion of B cells, and production of cardiac autoantibodies.</p>
          </list-item>
        </list>
        <p>Rheumatic carditis occurs because of molecular mimicry of streptococcal antigens (like M protein) with cardiac antigens such that anti-streptococcal antibodies cross-react with cardiac myosin and valvular endothelium<xref ref-type="bibr" rid="article-25469.r17">[17]</xref>; however, their role in myocardial injury is debatable.<xref ref-type="bibr" rid="article-25469.r18">[18]</xref> Intracellular pathogens like&#x000a0;<italic toggle="yes">Borrelia,&#x000a0;Trypanosoma, or Toxoplasma</italic>&#x000a0;cause myocyte injury by direct invasion and intracellular proliferation<xref ref-type="bibr" rid="article-25469.r10">[10]</xref> However, the pathogenesis of Chagas' myocarditis is much more complicated and possibly involves multiple other mechanisms like parasite-mediated&#x000a0;myocytolysis, antibody-mediated cytotoxicity, and parasite-induced autoimmunity.<xref ref-type="bibr" rid="article-25469.r10">[10]</xref><xref ref-type="bibr" rid="article-25469.r19">[19]</xref> Spirochetal&#x000a0;diseases like Lyme carditis can sometimes worsen after the initiation of antibiotics because of the release of endotoxin-like products from widespread microbial killing, which triggers proinflammatory cytokines (Jarisch-Herxheimer reaction).<xref ref-type="bibr" rid="article-25469.r20">[20]</xref> Parasitic diseases could be secondary to encystment in the cardiac muscle itself (as seen in cysticercosis) or from activation of immune response leading to eosinophilic myocarditis.<xref ref-type="bibr" rid="article-25469.r10">[10]</xref> Toxicity with heavy metals like copper or iron (including hemochromatosis) and certain chemotherapeutic&#x000a0;agents like trastuzumab or anthracycline agents (doxorubicin, daunorubicin) can also cause myocyte injury. Cocaine and amphetamines can cause myocarditis because of catecholamine excess, which can induce apoptosis through &#x000df;1-receptor and also increase oxidative stress and local inflammation by inactivating superoxide dismutase.<xref ref-type="bibr" rid="article-25469.r21">[21]</xref> This enzymatic inactivation might also be the mechanism behind pheochromocytoma or thyrotoxicosis-induced myocarditis. The pathogenesis of giant cell myocarditis is unknown; however, many&#x000a0;ascribe it to autoimmune origins because of its association with thymomas and other autoimmune disorders.<xref ref-type="bibr" rid="article-25469.r22">[22]</xref><xref ref-type="bibr" rid="article-25469.r13">[13]</xref></p>
        <p>Studies have implicated both cell-mediated, and antibody-mediated immune responses in the pathogenesis of myocarditis, and CD4+ T cells play a major role in both pathways.<xref ref-type="bibr" rid="article-25469.r23">[23]</xref><xref ref-type="bibr" rid="article-25469.r24">[24]</xref> The Th1 subtype of CD4+ T cells activate the CD8+ cytotoxic T cells whereas the Th2 cells induce antibody production by the B cells.&#x000a0;Some of these autoantibodies have a cytopathic or cardio-depressant effect,<xref ref-type="bibr" rid="article-25469.r25">[25]</xref><xref ref-type="bibr" rid="article-25469.r26">[26]</xref>, while others might just be markers of inflammation.&#x000a0;An abnormal immunologic response causes incomplete microbial clearance and/or persistent autoimmune myocyte injury and inflammation leading to chronic myocarditis.<xref ref-type="bibr" rid="article-25469.r27">[27]</xref><xref ref-type="bibr" rid="article-25469.r28">[28]</xref><xref ref-type="bibr" rid="article-25469.r29">[29]</xref> This condition may be chronic microbial myocarditis (ongoing inflammation with detectable microbes and no autoantibodies), chronic autoreactive myocarditis (persistent inflammation and autoantibodies&#x000a0;without microbes), and chronic microbial and immune myocarditis (ongoing inflammation&#x000a0;in the presence of both microbes and autoantibodies).<xref ref-type="bibr" rid="article-25469.r5">[5]</xref> Dilated cardiomyopathy develops when the inflammation resolves, but there is&#x000a0;a persistence of&#x000a0;myocyte destruction and cardiac&#x000a0;remodeling.<xref ref-type="bibr" rid="article-25469.r5">[5]</xref></p>
      </sec>
      <sec id="article-25469.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Aretz et al. proposed the Dallas criteria in 1986 for the histopathologic diagnosis of acute myocarditis, which requires evidence of inflammatory cellular infiltrate and myocyte necrosis for a diagnosis of acute myocarditis; whereas borderline myocarditis describes an inflammatory infiltrate in the absence of myocyte necrosis.<xref ref-type="bibr" rid="article-25469.r30">[30]</xref><xref ref-type="bibr" rid="article-25469.r31">[31]</xref> However, studies have shown this classification to be inadequate because of interobserver variability in interpretation and poor sensitivity because of sampling error.<xref ref-type="bibr" rid="article-25469.r32">[32]</xref><xref ref-type="bibr" rid="article-25469.r33">[33]</xref> It also provides no prognostic information because of the lack of characterization of the&#x000a0;infiltrate.&#x000a0;In contrast, the use of immunohistochemical staining for cell surface antigens (like CD3 and CD4 for T cells, CD20 for B cells, and CD68 for macrophages) and human leukocyte antigens (HLA-DR, which are often over-expressed in non-infective autoimmune myocarditis, and may influence treatment decisions) not only makes EMB more sensitive but also helps classify myocarditis as lymphocytic, granulomatous or giant cell or eosinophilic. A new immunohistochemical criterion proposed in a report by the European Society of Cardiology involves the detection of =14 leucocytes/mm including up to 4 monocytes/mm with the presence of CD3 positive T-lymphocytes =7 cells/mm.<xref ref-type="bibr" rid="article-25469.r5">[5]</xref> Chronic myocarditis also displays&#x000a0;areas of fibrosis and remodeling besides active inflammation.</p>
        <p>Some&#x000a0;types of myocarditis have very characteristic morphologies. Aschoff nodules with central fibrinoid necrosis and&#x000a0;Anitschkow&#x000a0;cells are the hallmark findings of rheumatic carditis, typically seen in perivascular regions. Patients with toxoplasma myocarditis may have&#x000a0;pseudocysts&#x000a0;containing <italic toggle="yes">Toxoplasma&#x000a0;tachyzoites</italic>&#x000a0;in the non-inflamed&#x000a0;regions of the myocardium.<xref ref-type="bibr" rid="article-25469.r34">[34]</xref><xref ref-type="bibr" rid="article-25469.r35">[35]</xref> Giant cell myocarditis has multinucleated giant cells on a biopsy whereas cardiac sarcoidosis may reveal noncaseating granulomas.&#x000a0;Myocarditis because of drug hypersensitivity, parasitic infections,&#x000a0;hypereosinophilic&#x000a0;syndrome, Loffler syndrome, and Churg-Strauss syndrome display a predominantly eosinophilic infiltrate with variable myocyte necrosis and may involve endocardial and valvular fibrosis.<xref ref-type="bibr" rid="article-25469.r36">[36]</xref><xref ref-type="bibr" rid="article-25469.r37">[37]</xref><xref ref-type="bibr" rid="article-25469.r38">[38]</xref></p>
      </sec>
      <sec id="article-25469.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Myocarditis can present with a broad spectrum of symptoms of varying severity. From being asymptomatic to mild nonspecific symptoms like fever, myalgias, decreased exercise tolerance, or pleuritic chest pain, it can also mimic angina/MI and heart failure, or present with life-threatening arrhythmia or cardiogenic shock. In their position statement on myocardial and pericardial diseases, the European Society of Cardiology broadly grouped myocarditis symptoms into four classes<xref ref-type="bibr" rid="article-25469.r5">[5]</xref>:</p>
        <list list-type="order">
          <list-item>
            <p><italic toggle="yes">Acute coronary syndrome-like presentation,&#x000a0;</italic>associated with ST-T wave changes, the elevation of troponins, and even regional or global wall motion abnormalities on echocardiography, but with no evidence of CAD on coronary angiography. A respiratory or gastrointestinal illness often precedes symptoms by approximately 1-4 weeks.</p>
          </list-item>
          <list-item>
            <p>New onset or worsening heart failure lasting for fewer than 3 months, in the absence of CAD or known causes of heart failure, with symptoms of dyspnea, orthopnea, palpitations, pedal edema, fatigue, and chest discomfort. Physical examination may reveal a distressed, tachypneic individual with sinus tachycardia, an audible S3, bilateral crackles, or jugular venous distension. An echocardiogram can show impaired left or right ventricular systolic function with or without increased wall thickness or ventricular dimensions, and patients might have associated atrioventricular or bundle branch blocks.;</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">Chronic heart failure&#x000a0;</italic>with symptoms lasting for over 3 months, in the absence of CAD or known causes of heart failure</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">Life-threatening conditions like</italic> ventricular arrhythmias or cardiogenic shock with severely reduced ejection fraction.</p>
          </list-item>
        </list>
        <p>Patients might also display signs and symptoms of the causative disease. For example, a patient with Chagas&#x02019; disease might present with swelling at the infection site (chagoma), fever, myalgia, rash, lymphadenopathy or eyelid swelling (Roma&#x000f1;a's sign) in the acute phase; or with dysphagia (megaesophagus), constipation (megacolon) or orthostatic hypotension (dysautonomia) in the chronic phase. Similarly, Lyme carditis may present with rash, flu-like symptoms, joint pain, facial palsy, or neuropathy.</p>
        <p>Liebermann et al. introduced&#x000a0;a&#x000a0;clinicopathologic classification in&#x000a0;1991 that&#x000a0;utilized&#x000a0;clinical presentations to differentiate fulminant myocarditis from active lymphocytic myocarditis (acute, chronic active, or chronic persistent).<xref ref-type="bibr" rid="article-25469.r39">[39]</xref> Fulminant myocarditis has an acute onset of two to three days, with severe decompensation of ventricular function that may require circulatory support, but typically resolves spontaneously. A viral prodrome might precede fulminant myocarditis. Conversely, giant cell myocarditis&#x000a0;and cardiac sarcoidosis might have a more protracted course but lead to worse outcomes. They can cause sustained ventricular tachycardias, high degree heart blocks, and progressively worsening heart failure refractory to therapy&#x000a0;which may require a cardiac transplant.<xref ref-type="bibr" rid="article-25469.r40">[40]</xref><xref ref-type="bibr" rid="article-25469.r41">[41]</xref></p>
      </sec>
      <sec id="article-25469.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Myocarditis typically causes nonspecific changes in the EKG but can include diffuse ST-segment elevations that are typically concave (as opposed to convex morphology in STEMI). Lyme carditis, giant cell myocarditis, and cardiac sarcoidosis often present with AV blocks or bundle branch blocks. Patients with a prolonged QRS duration have a greater risk of cardiac transplant or death in the setting of clinically suspected&#x000a0;myocarditis.<xref ref-type="bibr" rid="article-25469.r42">[42]</xref></p>
        <p>Myocarditis may cause elevation of cardiac biomarkers like troponin T or troponin&#x000a0;I, but this is more sensitive than specific.<xref ref-type="bibr" rid="article-25469.r43">[43]</xref> Troponin I is more commonly elevated compared to creatinine kinase MB.<xref ref-type="bibr" rid="article-25469.r43">[43]</xref><xref ref-type="bibr" rid="article-25469.r44">[44]</xref> Patients with heart failure symptoms might have an elevated brain natriuretic peptide (BNP) level. Acute phase reactants like ESR or CRP may also be elevated, but are non-specific. A complete blood count may reveal eosinophilia in eosinophilic myocarditis.</p>
        <p>An echocardiogram may or may&#x000a0;not&#x000a0;reveal&#x000a0;an impairment&#x000a0;of&#x000a0;ventricular function,&#x000a0;with or&#x000a0;without&#x000a0;global or&#x000a0;regional wall motion abnormalities. Both acute and chronic myocarditis&#x000a0;can&#x000a0;present with an increase in the size of the ventricular chambers; acute myocarditis can have a normal-to-thickened myocardium whereas chronic myocarditis more commonly correlates with thinning and scarring of the ventricular walls. However, it can morphologically resemble any of the three cardiomyopathies (dilated,&#x000a0;restrictive, or hypertrophic).<xref ref-type="bibr" rid="article-25469.r45">[45]</xref> Fulminant myocarditis causes decreased contractility because of interstitial edema in the myocardium; there&#x000a0;might also be a slight thickening of the ventricular walls because of the edema, but the ventricles remain non-dilated.<xref ref-type="bibr" rid="article-25469.r46">[46]</xref> Chronic Chagas&#x02019; myocarditis can cause an apical ventricular aneurysm in up to 55% of cases.<xref ref-type="bibr" rid="article-25469.r10">[10]</xref> Additionally, echocardiography can rule out other causes of heart failure like valvular diseases.</p>
        <p>Microbial diagnosis of myocarditis requires respective serologies. A patient with acute myocarditis will&#x000a0;have&#x000a0;IgM&#x000a0;immunoglobulins whereas chronic microbial myocarditis will show&#x000a0;IgG&#x000a0;antibodies. Adding viral PCR for DNA or RNA&#x000a0;on the EMB specimen may improve the diagnostic yield.</p>
        <p>Studies have linked several autoantibodies with myocarditis; some target cardiac and muscle-specific antigens like anti-heart antibodies (AHA), anti-intercalated disk antibodies (AIDA), and anti-sarcolemmal antibodies (ASA).<xref ref-type="bibr" rid="article-25469.r5">[5]</xref> AHA and AIDA are also predictors of the development of dilated cardiomyopathy in relatives.<xref ref-type="bibr" rid="article-25469.r26">[26]</xref> Others like anti-muscarinic acetylcholine receptor-2 and anti-adenine nucleotide&#x000a0;translocator&#x000a0;(anti-ANT) antibodies exert a negative inotropic effect such that immunoadsorption leads to improvement of cardiac function.<xref ref-type="bibr" rid="article-25469.r26">[26]</xref><xref ref-type="bibr" rid="article-25469.r47">[47]</xref> However,&#x000a0;there is no commercially available assay&#x000a0;so far that can reliably diagnose myocarditis.</p>
        <p>Nuclear imaging with Gallium-67 scintigraphy, Thallium-201 scan, or 18-fluorodeoxyglucose&#x000a0;positron emission tomography&#x000a0;have poor specificity but can help detect sarcoidosis in its acute phase and also be useful&#x000a0;in monitoring the progression of the disease.<xref ref-type="bibr" rid="article-25469.r48">[48]</xref><xref ref-type="bibr" rid="article-25469.r49">[49]</xref></p>
        <p>Cardiac MRI (CMR) has developed as a promising mode of non-invasive diagnosis of myocarditis. In patients with clinically suspected myocarditis, the Lake Louise criteria help&#x000a0;determine if the CMR findings are consistent with myocarditis.<xref ref-type="bibr" rid="article-25469.r50">[50]</xref> These criteria require at least two out of the following three criteria:</p>
        <list list-type="order">
          <list-item>
            <p>Increase in global or regional myocardial signal intensity in T2-weighted images, suggestive of myocardial edema</p>
          </list-item>
          <list-item>
            <p>Early gadolinium enhancement of the myocardium suggestive of hyperemia and capillary leakage (markers of inflammation), and an increased ratio of signal intensity between myocardium and skeletal muscles in T1-weighted gadolinium-enhanced images</p>
          </list-item>
          <list-item>
            <p>At least one focal lesion of late gadolinium enhancement (in inversion recovery-prepared gadolinium-enhanced T1-weighted images) is suggestive of myocyte injury and/or scar due to myocarditis; this must be in the non-ischemic regional distribution (sub-epicardium&#x000a0;or mid-wall, rather than the sub-endocardium&#x000a0;which&#x000a0;is involved&#x000a0;in myocardial infarction)</p>
          </list-item>
        </list>
        <p>If high clinical suspicion exists for myocarditis with recent onset of symptoms, but the CMR&#x000a0;does not meet the&#x000a0;Lake Louise criteria, then the CMR must&#x000a0;be repeated&#x000a0;in 1-2 weeks.</p>
        <p>&#x000a0;Endomyocardial&#x000a0;biopsy (EMB) is the only means of a definitive diagnosis of myocarditis and must fulfill&#x000a0;the histologic and immunohistochemical criteria discussed&#x000a0;before. Since it is an invasive procedure with significant morbidity, it is not&#x000a0;feasible&#x000a0;in every patient. The European Society of Cardiology proposes that EMB should&#x000a0;be performed&#x000a0;in patients with clinically suspected myocarditis after ruling out ischemia with coronary angiography.<xref ref-type="bibr" rid="article-25469.r5">[5]</xref></p>
        <p>The patient has clinically suspected myocarditis if he has one or more "clinical presentations" with one or more "diagnostic criteria"; or if he/she is asymptomatic, he/she must meet 2 or more "diagnostic criteria" from different categories.<xref ref-type="bibr" rid="article-25469.r5">[5]</xref> Clinical presentations include:</p>
        <list list-type="order">
          <list-item>
            <p>Acute chest pain (which can be pericarditic or pseudo-ischemic)</p>
          </list-item>
          <list-item>
            <p>New onset/ acute worsening (&#x0003c;3 months)</p>
          </list-item>
          <list-item>
            <p>Chronic (&#x0003e;3 months) heart failure (with dyspnea and/or fatigue&#x000a0;with or without the left and/or right heart failure signs)</p>
          </list-item>
          <list-item>
            <p>Arrhythmias&#x000a0;(palpitations, syncope, other unexplained arrhythmia symptoms, or aborted sudden cardiac death)</p>
          </list-item>
          <list-item>
            <p>Unexplained cardiogenic shock</p>
          </list-item>
        </list>
        <p>Diagnostic criteria include:</p>
        <list list-type="order">
          <list-item>
            <p>Newly abnormal 12-lead EKG, Holter or stress testing</p>
          </list-item>
          <list-item>
            <p>Elevated&#x000a0;myocytolysis&#x000a0;markers like Troponin T or Troponin I,</p>
          </list-item>
          <list-item>
            <p>New and otherwise unexplained functional and structural abnormalities on cardiac imaging (echocardiography, angiography, or MRI)</p>
          </list-item>
          <list-item>
            <p>Tissue characterization by&#x000a0;CMR (including edema and/or late gadolinium enhancement of myocarditis pattern).&#x000a0;</p>
          </list-item>
        </list>
        <p>All patients raising clinical suspicion of myocarditis should be admitted&#x000a0;to the hospital for observation. Patients must have a 12-lead EKG testing and a transthoracic echocardiogram and should&#x000a0;be considered&#x000a0;for coronary angiography to rule out ischemic heart disease. If the patient is clinically stable, a cardiac MRI may precede EMB for further characterization; but if the patient has a life-threatening presentation, he/she must undergo an EMB without delay.<xref ref-type="bibr" rid="article-25469.r5">[5]</xref> An EMB supplemented with immunohistochemical staining, PCR, and HLA typing can identify the etiology (microbial versus autoimmune) and the&#x000a0;type of&#x000a0;inflammatory response&#x000a0;(lymphocytic, eosinophilic, giant cell, and sarcoidosis), and can guide the treatment and prognosis.&#x000a0;</p>
      </sec>
      <sec id="article-25469.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Treatment of myocarditis can be symptomatic or etiologic. Symptomatic treatment involves the management of heart failure and arrhythmias based on current guidelines.</p>
        <p>Hemodynamically unstable patients&#x000a0;need intensive care and may require inotropic support, ventricular assist devices, or extracorporeal membrane oxygenation (ECMO) in cases of severe ventricular dysfunction as a bridge to cardiac transplant or recovery.<xref ref-type="bibr" rid="article-25469.r51">[51]</xref><xref ref-type="bibr" rid="article-25469.r52">[52]</xref> Hemodynamically stable patients with ventricular dysfunction&#x000a0;are treatable with angiotensin-converting enzyme inhibitors (ACE-I), angiotensin receptor blockers (ARB), or angiotensin receptor-&#x000a0;neprilysin&#x000a0;inhibitors (ARNI), along with beta-blockers, aldosterone receptor antagonists, and diuretics as per&#x000a0;the ACC/AHA/HFSA heart failure recommendations.<xref ref-type="bibr" rid="article-25469.r53">[53]</xref></p>
        <p>Myocarditis patients&#x000a0;may present with conduction abnormalities like complete A-V blocks, which can&#x000a0;rapidly evolve into life-threatening arrhythmias. As a result, temporary or permanent pacing may&#x000a0;be necessary.&#x000a0;Ventricular tachycardias&#x000a0;can be&#x000a0;treated&#x000a0;with amiodarone or may require an implantable cardioverter-defibrillator (ICD) as a bridge to transplant or recovery.<xref ref-type="bibr" rid="article-25469.r54">[54]</xref> Radio-frequency&#x000a0;catheter ablation can also be used&#x000a0;to control recurrent ventricular arrhythmias.<xref ref-type="bibr" rid="article-25469.r54">[54]</xref> A wearable cardioverter-defibrillator is&#x000a0;another bridging alternative for the control of transient arrhythmias.<xref ref-type="bibr" rid="article-25469.r55">[55]</xref> Patients with cardiac sarcoidosis require an ICD if their left ventricular ejection fraction is less than 35% and their life expectancy is greater than 1 year.<xref ref-type="bibr" rid="article-25469.r54">[54]</xref></p>
        <p>Etiologic management includes appropriate antimicrobial therapy for infective causes (like ceftriaxone or doxycycline in Lyme&#x000a0;carditis, benznidazole, or&#x000a0;nifurtimox&#x000a0;for Chagas disease).<xref ref-type="bibr" rid="article-25469.r10">[10]</xref> Drug hypersensitivity reactions and toxic myocarditis respond to the cessation of the offending agents.&#x000a0; Autoimmune myocarditis, including giant cell myocarditis, shows a variable response to immunosuppressive therapy.<xref ref-type="bibr" rid="article-25469.r56">[56]</xref><xref ref-type="bibr" rid="article-25469.r57">[57]</xref><xref ref-type="bibr" rid="article-25469.r58">[58]</xref> Common regimens include steroids alone, azathioprine and steroids, or cyclosporine A, azathioprine, and steroids.&#x000a0;A trial of immunomodulatory therapies like&#x000a0;intravenous immunoglobulins (IVIG) may be given&#x000a0;in patients that do not respond to conventional immunosuppression.<xref ref-type="bibr" rid="article-25469.r59">[59]</xref> Many have studied the role of antiviral therapies in the treatment of viral myocarditis; however, there are no clear&#x000a0;guidelines so far;&#x000a0;infectious disease specialists should be&#x000a0;consulted&#x000a0;for the initiation of therapy.<xref ref-type="bibr" rid="article-25469.r5">[5]</xref> Similarly, while immunoadsorption of certain antibodies has shown an improvement&#x000a0;of cardiac function in&#x000a0;small randomized controlled trials, there are no current recommendations for their routine use.</p>
        <p>Non-steroidal anti-inflammatory drugs (NSAIDs) do not seem to have any benefit in myocarditis; in fact,&#x000a0;their&#x000a0;use&#x000a0;in myocarditis correlates with greater mortality.<xref ref-type="bibr" rid="article-25469.r5">[5]</xref><xref ref-type="bibr" rid="article-25469.r60">[60]</xref><xref ref-type="bibr" rid="article-25469.r15">[15]</xref> Patients must avoid physical activity because of a greater risk&#x000a0;for sudden cardiac death<xref ref-type="bibr" rid="article-25469.r61">[61]</xref>; an&#x000a0;exercise stress test must not&#x000a0;be performed&#x000a0;for the evaluation of coronary artery disease.</p>
      </sec>
      <sec id="article-25469.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Myocarditis mimics several conditions; therefore, one must carefully consider its differential diagnoses.&#x000a0;Acute coronary syndrome, valvular disease, infective endocarditis, cardiac tamponade,&#x000a0;and&#x000a0;pericarditis must be ruled&#x000a0;out. Right ventricular myocarditis can present like arrhythmogenic right ventricular cardiomyopathy.<xref ref-type="bibr" rid="article-25469.r62">[62]</xref><xref ref-type="bibr" rid="article-25469.r63">[63]</xref> Other conditions that may resemble myocarditis include hypertrophic cardiomyopathy, restrictive diseases like cardiac amyloidosis, ischemic cardiomyopathy, coronary artery vasospasm, peripartum cardiomyopathy, ventricular tachycardia, interstitial pulmonary fibrosis,&#x000a0;and high altitude-induced pulmonary edema.</p>
      </sec>
      <sec id="article-25469.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The prognosis of myocarditis varies by the type and etiology of the disease. Viral myocarditis usually resolves spontaneously. Even fulminant myocarditis which&#x000a0;is marked&#x000a0;by severe ventricular impairment and multiple foci of myocarditis (while it might require aggressive interventions during the active phase of the disease) eventually resolves completely.<xref ref-type="bibr" rid="article-25469.r64">[64]</xref><xref ref-type="bibr" rid="article-25469.r65">[65]</xref> However,&#x000a0;the persistence of the viral genome on PCR is a marker of a worse prognosis.<xref ref-type="bibr" rid="article-25469.r66">[66]</xref> Acute lymphocytic myocarditis is a broad category that includes immune-mediated causes and&#x000a0;has worse outcomes&#x000a0;compared to fulminant myocarditis.<xref ref-type="bibr" rid="article-25469.r64">[64]</xref><xref ref-type="bibr" rid="article-25469.r65">[65]</xref> Giant cell myocarditis has very poor outcomes including higher incidences of arrhythmias, sudden cardiac death, and refractory heart failure requiring a cardiac transplant.<xref ref-type="bibr" rid="article-25469.r40">[40]</xref> There might be a recurrence of giant cell myocarditis in the donor heart after transplantation; however, the disease in the allograft responds favorably to treatment.<xref ref-type="bibr" rid="article-25469.r58">[58]</xref> Eosinophilic myocarditis has a variable prognosis; drug hypersensitivity syndromes, hyper-eosinophilic, and parasitic myocarditis may resolve with drug cessation, antimicrobial therapy, and corticosteroid therapy respectively. There is a rarer, more aggressive entity called acute necrotizing eosinophilic myocarditis that correlates with higher death rates.<xref ref-type="bibr" rid="article-25469.r67">[67]</xref></p>
        <p>The presence of biventricular dysfunction at the time of diagnosis is a major predictor of death or the need for a cardiac transplant.<xref ref-type="bibr" rid="article-25469.r66">[66]</xref> Right ventricular dysfunction is an independent predictor of adverse outcomes.<xref ref-type="bibr" rid="article-25469.r68">[68]</xref> Myocarditis can also cause deterioration of concomitant cardiac conditions like cardiac amyloidosis and hypertrophic cardiomyopathy, especially in cases with persistent viral genome. Some studies have linked elevated serum soluble Fas (sFas) and soluble Fas ligand (sFasL) levels at the time of presentation with an increased risk of death.<xref ref-type="bibr" rid="article-25469.r69">[69]</xref><xref ref-type="bibr" rid="article-25469.r70">[70]</xref><xref ref-type="bibr" rid="article-25469.r71">[71]</xref></p>
      </sec>
      <sec id="article-25469.s12" sec-type="Complications">
        <title>Complications</title>
        <p>Immediate complications of myocarditis include cardiogenic shock, ventricular arrhythmias,&#x000a0;and sudden cardiac death. Unresolved myocarditis can progress to dilated cardiomyopathy,&#x000a0;heart failure with reduced ejection fraction,&#x000a0;areas of focal hypokinesis, and ventricular aneurysms that may also lead to intracardiac thrombi, which may further result in a stroke or MI. Dilated cardiomyopathy is perhaps the most common sequelae&#x000a0;of myocarditis that develops in up to 30% of biopsy-proven cases of myocarditis.<xref ref-type="bibr" rid="article-25469.r5">[5]</xref><xref ref-type="bibr" rid="article-25469.r72">[72]</xref><xref ref-type="bibr" rid="article-25469.r11">[11]</xref> Cases of eosinophilic myocarditis may also cause endocardial fibrosis and lead to valvular diseases.<xref ref-type="bibr" rid="article-25469.r73">[73]</xref></p>
      </sec>
      <sec id="article-25469.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patients should receive education about the course of the disease and their respective prognoses.&#x000a0;Patients have an increased risk of sudden death and&#x000a0;should avoid physical activity until the disease has completely resolved (acute myocarditis), or until 6 months from the onset of symptoms.<xref ref-type="bibr" rid="article-25469.r61">[61]</xref> These recommendations apply to both athletes and non-athletes irrespective of age, gender, severity, or treatment. Athletes must undergo pre-participation screening before they can resume competitive sports and every 6 months thereafter.<xref ref-type="bibr" rid="article-25469.r61">[61]</xref></p>
      </sec>
      <sec id="article-25469.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>All patients with clinically suspected myocarditis must undergo vigilant monitoring in the hospital for acute&#x000a0;decompensation.</p>
        <list list-type="bullet">
          <list-item>
            <p>Clinically unstable patients must undergo endomyocardial biopsy (EMB) without delay; for stable patients, one might consider a cardiac MRI.</p>
          </list-item>
          <list-item>
            <p>Sampling for EMB must be adequate, and&#x000a0;it should be supplemented by immunohistochemical&#x000a0;staining, HLA typing PCR, and viral genome analysis; inconclusive results delay treatment.</p>
          </list-item>
          <list-item>
            <p>Etiologic treatment&#x000a0;for myocarditis cannot be started&#x000a0;without EMB, which differentiates infective from autoimmune causes, and determines whether the patient needs antimicrobial or immunosuppressive therapy.</p>
          </list-item>
          <list-item>
            <p>Prognostic information plays a vital role in guiding treatment; for example, a patient with fulminant myocarditis may require aggressive interventions like ventricular assist devices or ECMO, because he/she&#x000a0;is expected&#x000a0;to make a full recovery after&#x000a0;the resolution of&#x000a0;myocarditis.</p>
          </list-item>
          <list-item>
            <p>Patients must avoid physical activity until complete resolution of symptoms, or at least&#x000a0;until 6 months from the onset because of increased risk of sudden death.</p>
          </list-item>
        </list>
        <p>Clinicians, nurses, and pharmacists caring for a patient with myocarditis must work together to provide close monitoring and alert the team when there are signs or symptoms of developing decompensation.</p>
      </sec>
      <sec id="article-25469.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=25469&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=25469">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/heart-health/nonviral-myocarditis/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=25469">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/25469/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=25469">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-25469.s16">
        <title>References</title>
        <ref id="article-25469.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Olsen</surname>
                <given-names>EG</given-names>
              </name>
            </person-group>
            <article-title>Myocarditis--a case of mistaken identity?</article-title>
            <source>Br Heart J</source>
            <year>1983</year>
            <month>Oct</month>
            <volume>50</volume>
            <issue>4</issue>
            <fpage>303</fpage>
            <page-range>303-11</page-range>
            <pub-id pub-id-type="pmid">6626390</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25469.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Richardson</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>McKenna</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Bristow</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Maisch</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Mautner</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>O'Connell</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Olsen</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Thiene</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Goodwin</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Gyarfas</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Martin</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Nordet</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies.</article-title>
            <source>Circulation</source>
            <year>1996</year>
            <month>Mar</month>
            <day>01</day>
            <volume>93</volume>
            <issue>5</issue>
            <fpage>841</fpage>
            <page-range>841-2</page-range>
            <pub-id pub-id-type="pmid">8598070</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25469.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rose</surname>
                <given-names>NR</given-names>
              </name>
              <name>
                <surname>Neumann</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Herskowitz</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Coxsackievirus myocarditis.</article-title>
            <source>Adv Intern Med</source>
            <year>1992</year>
            <volume>37</volume>
            <fpage>411</fpage>
            <page-range>411-29</page-range>
            <pub-id pub-id-type="pmid">1558005</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25469.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Klingel</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Sauter</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bock</surname>
                <given-names>CT</given-names>
              </name>
              <name>
                <surname>Szalay</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Schnorr</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Kandolf</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Molecular pathology of inflammatory cardiomyopathy.</article-title>
            <source>Med Microbiol Immunol</source>
            <year>2004</year>
            <month>May</month>
            <volume>193</volume>
            <issue>2-3</issue>
            <fpage>101</fpage>
            <page-range>101-7</page-range>
            <pub-id pub-id-type="pmid">12920583</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25469.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Caforio</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Pankuweit</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Arbustini</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Basso</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Gimeno-Blanes</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Felix</surname>
                <given-names>SB</given-names>
              </name>
              <name>
                <surname>Fu</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Heli&#x000f6;</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Heymans</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Jahns</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Klingel</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Linhart</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Maisch</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>McKenna</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Mogensen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Pinto</surname>
                <given-names>YM</given-names>
              </name>
              <name>
                <surname>Ristic</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Schultheiss</surname>
                <given-names>HP</given-names>
              </name>
              <name>
                <surname>Seggewiss</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Tavazzi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Thiene</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Yilmaz</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Charron</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Elliott</surname>
                <given-names>PM</given-names>
              </name>
              <collab>European Society of Cardiology Working Group on Myocardial and Pericardial Diseases</collab>
            </person-group>
            <article-title>Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases.</article-title>
            <source>Eur Heart J</source>
            <year>2013</year>
            <month>Sep</month>
            <volume>34</volume>
            <issue>33</issue>
            <fpage>2636</fpage>
            <page-range>2636-48, 2648a-2648d</page-range>
            <pub-id pub-id-type="pmid">23824828</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25469.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Papamichalis</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Argyraki</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Papamichalis</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Loukopoulos</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Dalekos</surname>
                <given-names>GN</given-names>
              </name>
              <name>
                <surname>Rigopoulou</surname>
                <given-names>EI</given-names>
              </name>
            </person-group>
            <article-title>Salmonella enteritidis Infection Complicated by Acute Myocarditis: A Case Report and Review of the Literature.</article-title>
            <source>Cardiol Res Pract</source>
            <year>2011</year>
            <volume>2011</volume>
            <fpage>574230</fpage>
            <pub-id pub-id-type="pmid">21637719</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25469.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Childs</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Gupta</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Salmonella enteritidis induced myocarditis in a 16-year-old girl.</article-title>
            <source>BMJ Case Rep</source>
            <year>2012</year>
            <month>Nov</month>
            <day>27</day>
            <volume>2012</volume>
            <pub-id pub-id-type="pmid">23188875</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25469.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Villablanca</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Mohananey</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Meier</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Yap</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Chouksey</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Abegunde</surname>
                <given-names>AT</given-names>
              </name>
            </person-group>
            <article-title>Salmonella Berta myocarditis: Case report and systematic review of non-typhoid Salmonella myocarditis.</article-title>
            <source>World J Cardiol</source>
            <year>2015</year>
            <month>Dec</month>
            <day>26</day>
            <volume>7</volume>
            <issue>12</issue>
            <fpage>931</fpage>
            <page-range>931-7</page-range>
            <pub-id pub-id-type="pmid">26730299</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25469.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Le-Van-Diem</surname>
              </name>
              <name>
                <surname>Arnold</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Typhoid fever with myocarditis.</article-title>
            <source>Am J Trop Med Hyg</source>
            <year>1974</year>
            <month>Mar</month>
            <volume>23</volume>
            <issue>2</issue>
            <fpage>218</fpage>
            <page-range>218-21</page-range>
            <pub-id pub-id-type="pmid">4274141</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25469.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hidron</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Vogenthaler</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Santos-Preciado</surname>
                <given-names>JI</given-names>
              </name>
              <name>
                <surname>Rodriguez-Morales</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Franco-Paredes</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Rassi</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Cardiac involvement with parasitic infections.</article-title>
            <source>Clin Microbiol Rev</source>
            <year>2010</year>
            <month>Apr</month>
            <volume>23</volume>
            <issue>2</issue>
            <fpage>324</fpage>
            <page-range>324-49</page-range>
            <pub-id pub-id-type="pmid">20375355</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25469.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Towbin</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Lowe</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Colan</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Sleeper</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Orav</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Clunie</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Messere</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Cox</surname>
                <given-names>GF</given-names>
              </name>
              <name>
                <surname>Lurie</surname>
                <given-names>PR</given-names>
              </name>
              <name>
                <surname>Hsu</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Canter</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Wilkinson</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Lipshultz</surname>
                <given-names>SE</given-names>
              </name>
            </person-group>
            <article-title>Incidence, causes, and outcomes of dilated cardiomyopathy in children.</article-title>
            <source>JAMA</source>
            <year>2006</year>
            <month>Oct</month>
            <day>18</day>
            <volume>296</volume>
            <issue>15</issue>
            <fpage>1867</fpage>
            <page-range>1867-76</page-range>
            <pub-id pub-id-type="pmid">17047217</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25469.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Amabile</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Fraisse</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bouvenot</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Chetaille</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Ovaert</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Outcome of acute fulminant myocarditis in children.</article-title>
            <source>Heart</source>
            <year>2006</year>
            <month>Sep</month>
            <volume>92</volume>
            <issue>9</issue>
            <fpage>1269</fpage>
            <page-range>1269-73</page-range>
            <pub-id pub-id-type="pmid">16449512</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25469.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cooper</surname>
                <given-names>LT</given-names>
              </name>
              <name>
                <surname>Berry</surname>
                <given-names>GJ</given-names>
              </name>
              <name>
                <surname>Shabetai</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Idiopathic giant-cell myocarditis--natural history and treatment. Multicenter Giant Cell Myocarditis Study Group Investigators.</article-title>
            <source>N Engl J Med</source>
            <year>1997</year>
            <month>Jun</month>
            <day>26</day>
            <volume>336</volume>
            <issue>26</issue>
            <fpage>1860</fpage>
            <page-range>1860-6</page-range>
            <pub-id pub-id-type="pmid">9197214</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25469.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fairweather</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Cooper</surname>
                <given-names>LT</given-names>
              </name>
              <name>
                <surname>Blauwet</surname>
                <given-names>LA</given-names>
              </name>
            </person-group>
            <article-title>Sex and gender differences in myocarditis and dilated cardiomyopathy.</article-title>
            <source>Curr Probl Cardiol</source>
            <year>2013</year>
            <month>Jan</month>
            <volume>38</volume>
            <issue>1</issue>
            <fpage>7</fpage>
            <page-range>7-46</page-range>
            <pub-id pub-id-type="pmid">23158412</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25469.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Liu</surname>
                <given-names>PP</given-names>
              </name>
              <name>
                <surname>Mason</surname>
                <given-names>JW</given-names>
              </name>
            </person-group>
            <article-title>Advances in the understanding of myocarditis.</article-title>
            <source>Circulation</source>
            <year>2001</year>
            <month>Aug</month>
            <day>28</day>
            <volume>104</volume>
            <issue>9</issue>
            <fpage>1076</fpage>
            <page-range>1076-82</page-range>
            <pub-id pub-id-type="pmid">11524405</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25469.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Magnani</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Dec</surname>
                <given-names>GW</given-names>
              </name>
            </person-group>
            <article-title>Myocarditis: current trends in diagnosis and treatment.</article-title>
            <source>Circulation</source>
            <year>2006</year>
            <month>Feb</month>
            <day>14</day>
            <volume>113</volume>
            <issue>6</issue>
            <fpage>876</fpage>
            <page-range>876-90</page-range>
            <pub-id pub-id-type="pmid">16476862</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25469.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Galvin</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Hemric</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Ward</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Cunningham</surname>
                <given-names>MW</given-names>
              </name>
            </person-group>
            <article-title>Cytotoxic mAb from rheumatic carditis recognizes heart valves and laminin.</article-title>
            <source>J Clin Invest</source>
            <year>2000</year>
            <month>Jul</month>
            <volume>106</volume>
            <issue>2</issue>
            <fpage>217</fpage>
            <page-range>217-24</page-range>
            <pub-id pub-id-type="pmid">10903337</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25469.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tandon</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Rheumatic fever pathogenesis: Approach in research needs change.</article-title>
            <source>Ann Pediatr Cardiol</source>
            <year>2012</year>
            <month>Jul</month>
            <volume>5</volume>
            <issue>2</issue>
            <fpage>169</fpage>
            <page-range>169-78</page-range>
            <pub-id pub-id-type="pmid">23129908</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25469.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bonney</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Engman</surname>
                <given-names>DM</given-names>
              </name>
            </person-group>
            <article-title>Chagas heart disease pathogenesis: one mechanism or many?</article-title>
            <source>Curr Mol Med</source>
            <year>2008</year>
            <month>Sep</month>
            <volume>8</volume>
            <issue>6</issue>
            <fpage>510</fpage>
            <page-range>510-8</page-range>
            <pub-id pub-id-type="pmid">18781958</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25469.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Koene</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Boulware</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Kemperman</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Konety</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Groth</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Jessurun</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Eckman</surname>
                <given-names>PM</given-names>
              </name>
            </person-group>
            <article-title>Acute heart failure from lyme carditis.</article-title>
            <source>Circ Heart Fail</source>
            <year>2012</year>
            <month>Mar</month>
            <day>01</day>
            <volume>5</volume>
            <issue>2</issue>
            <fpage>e24</fpage>
            <page-range>e24-6</page-range>
            <pub-id pub-id-type="pmid">22438525</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25469.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Havakuk</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Rezkalla</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Kloner</surname>
                <given-names>RA</given-names>
              </name>
            </person-group>
            <article-title>The Cardiovascular Effects of Cocaine.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2017</year>
            <month>Jul</month>
            <day>04</day>
            <volume>70</volume>
            <issue>1</issue>
            <fpage>101</fpage>
            <page-range>101-113</page-range>
            <pub-id pub-id-type="pmid">28662796</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25469.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kilgallen</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Jackson</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Bankoff</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Salomon</surname>
                <given-names>RN</given-names>
              </name>
              <name>
                <surname>Surks</surname>
                <given-names>HK</given-names>
              </name>
            </person-group>
            <article-title>A case of giant cell myocarditis and malignant thymoma: a postmortem diagnosis by needle biopsy.</article-title>
            <source>Clin Cardiol</source>
            <year>1998</year>
            <month>Jan</month>
            <volume>21</volume>
            <issue>1</issue>
            <fpage>48</fpage>
            <page-range>48-51</page-range>
            <pub-id pub-id-type="pmid">9474466</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25469.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Eriksson</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Ricci</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Hunziker</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Kurrer</surname>
                <given-names>MO</given-names>
              </name>
              <name>
                <surname>Oudit</surname>
                <given-names>GY</given-names>
              </name>
              <name>
                <surname>Watts</surname>
                <given-names>TH</given-names>
              </name>
              <name>
                <surname>Sonderegger</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Bachmaier</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kopf</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Penninger</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Dendritic cell-induced autoimmune heart failure requires cooperation between adaptive and innate immunity.</article-title>
            <source>Nat Med</source>
            <year>2003</year>
            <month>Dec</month>
            <volume>9</volume>
            <issue>12</issue>
            <fpage>1484</fpage>
            <page-range>1484-90</page-range>
            <pub-id pub-id-type="pmid">14625544</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25469.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kodama</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hanawa</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Saeki</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hosono</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Inomata</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Suzuki</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Shibata</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Rat dilated cardiomyopathy after autoimmune giant cell myocarditis.</article-title>
            <source>Circ Res</source>
            <year>1994</year>
            <month>Aug</month>
            <volume>75</volume>
            <issue>2</issue>
            <fpage>278</fpage>
            <page-range>278-84</page-range>
            <pub-id pub-id-type="pmid">8033341</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25469.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kaya</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Afanasyeva</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Dohmen</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Schlichting</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Tretter</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Fairweather</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Holers</surname>
                <given-names>VM</given-names>
              </name>
              <name>
                <surname>Rose</surname>
                <given-names>NR</given-names>
              </name>
            </person-group>
            <article-title>Contribution of the innate immune system to autoimmune myocarditis: a role for complement.</article-title>
            <source>Nat Immunol</source>
            <year>2001</year>
            <month>Aug</month>
            <volume>2</volume>
            <issue>8</issue>
            <fpage>739</fpage>
            <page-range>739-45</page-range>
            <pub-id pub-id-type="pmid">11477411</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25469.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Caforio</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Tona</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Bottaro</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Vinci</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Dequal</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Daliento</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Thiene</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Iliceto</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Clinical implications of anti-heart autoantibodies in myocarditis and dilated cardiomyopathy.</article-title>
            <source>Autoimmunity</source>
            <year>2008</year>
            <month>Feb</month>
            <volume>41</volume>
            <issue>1</issue>
            <fpage>35</fpage>
            <page-range>35-45</page-range>
            <pub-id pub-id-type="pmid">18176863</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25469.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kawai</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future.</article-title>
            <source>Circulation</source>
            <year>1999</year>
            <month>Mar</month>
            <day>02</day>
            <volume>99</volume>
            <issue>8</issue>
            <fpage>1091</fpage>
            <page-range>1091-100</page-range>
            <pub-id pub-id-type="pmid">10051305</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25469.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Feldman</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>McNamara</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Myocarditis.</article-title>
            <source>N Engl J Med</source>
            <year>2000</year>
            <month>Nov</month>
            <day>09</day>
            <volume>343</volume>
            <issue>19</issue>
            <fpage>1388</fpage>
            <page-range>1388-98</page-range>
            <pub-id pub-id-type="pmid">11070105</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25469.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Opavsky</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Penninger</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Aitken</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Wen</surname>
                <given-names>WH</given-names>
              </name>
              <name>
                <surname>Dawood</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Mak</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Susceptibility to myocarditis is dependent on the response of alphabeta T lymphocytes to coxsackieviral infection.</article-title>
            <source>Circ Res</source>
            <year>1999</year>
            <month>Sep</month>
            <day>17</day>
            <volume>85</volume>
            <issue>6</issue>
            <fpage>551</fpage>
            <page-range>551-8</page-range>
            <pub-id pub-id-type="pmid">10488058</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25469.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Aretz</surname>
                <given-names>HT</given-names>
              </name>
              <name>
                <surname>Billingham</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Edwards</surname>
                <given-names>WD</given-names>
              </name>
              <name>
                <surname>Factor</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Fallon</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Fenoglio</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Olsen</surname>
                <given-names>EG</given-names>
              </name>
              <name>
                <surname>Schoen</surname>
                <given-names>FJ</given-names>
              </name>
            </person-group>
            <article-title>Myocarditis. A histopathologic definition and classification.</article-title>
            <source>Am J Cardiovasc Pathol</source>
            <year>1987</year>
            <month>Jan</month>
            <volume>1</volume>
            <issue>1</issue>
            <fpage>3</fpage>
            <page-range>3-14</page-range>
            <pub-id pub-id-type="pmid">3455232</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25469.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Aretz</surname>
                <given-names>HT</given-names>
              </name>
            </person-group>
            <article-title>Myocarditis: the Dallas criteria.</article-title>
            <source>Hum Pathol</source>
            <year>1987</year>
            <month>Jun</month>
            <volume>18</volume>
            <issue>6</issue>
            <fpage>619</fpage>
            <page-range>619-24</page-range>
            <pub-id pub-id-type="pmid">3297992</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25469.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chow</surname>
                <given-names>LH</given-names>
              </name>
              <name>
                <surname>Radio</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Sears</surname>
                <given-names>TD</given-names>
              </name>
              <name>
                <surname>McManus</surname>
                <given-names>BM</given-names>
              </name>
            </person-group>
            <article-title>Insensitivity of right ventricular endomyocardial biopsy in the diagnosis of myocarditis.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>1989</year>
            <month>Oct</month>
            <volume>14</volume>
            <issue>4</issue>
            <fpage>915</fpage>
            <page-range>915-20</page-range>
            <pub-id pub-id-type="pmid">2794278</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25469.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Baughman</surname>
                <given-names>KL</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis of myocarditis: death of Dallas criteria.</article-title>
            <source>Circulation</source>
            <year>2006</year>
            <month>Jan</month>
            <day>31</day>
            <volume>113</volume>
            <issue>4</issue>
            <fpage>593</fpage>
            <page-range>593-5</page-range>
            <pub-id pub-id-type="pmid">16449736</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25469.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fraser</surname>
                <given-names>WJ</given-names>
              </name>
              <name>
                <surname>Haffejee</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Cooper</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Rheumatic Aschoff nodules revisited: an immunohistological reappraisal of the cellular component.</article-title>
            <source>Histopathology</source>
            <year>1995</year>
            <month>Nov</month>
            <volume>27</volume>
            <issue>5</issue>
            <fpage>457</fpage>
            <page-range>457-61</page-range>
            <pub-id pub-id-type="pmid">8575737</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25469.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Strabelli</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Siciliano</surname>
                <given-names>RF</given-names>
              </name>
              <name>
                <surname>Vidal Campos</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bianchi Castelli</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bacal</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Bocchi</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Uip</surname>
                <given-names>DE</given-names>
              </name>
            </person-group>
            <article-title>Toxoplasma gondii Myocarditis after Adult Heart Transplantation: Successful Prophylaxis with Pyrimethamine.</article-title>
            <source>J Trop Med</source>
            <year>2012</year>
            <volume>2012</volume>
            <fpage>853562</fpage>
            <pub-id pub-id-type="pmid">23209479</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25469.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Corssmit</surname>
                <given-names>EP</given-names>
              </name>
              <name>
                <surname>Trip</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Durrer</surname>
                <given-names>JD</given-names>
              </name>
            </person-group>
            <article-title>L&#x000f6;ffler's endomyocarditis in the idiopathic hypereosinophilic syndrome.</article-title>
            <source>Cardiology</source>
            <year>1999</year>
            <volume>91</volume>
            <issue>4</issue>
            <fpage>272</fpage>
            <page-range>272-6</page-range>
            <pub-id pub-id-type="pmid">10545685</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25469.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cheung</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Constantine</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ahmadi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Shiau</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>LYC</given-names>
              </name>
            </person-group>
            <article-title>Eosinophilic Myocarditis.</article-title>
            <source>Am J Med Sci</source>
            <year>2017</year>
            <month>Nov</month>
            <volume>354</volume>
            <issue>5</issue>
            <fpage>486</fpage>
            <page-range>486-492</page-range>
            <pub-id pub-id-type="pmid">29173361</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25469.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sohn</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>Song</surname>
                <given-names>WJ</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>BK</given-names>
              </name>
              <name>
                <surname>Kang</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>SY</given-names>
              </name>
              <name>
                <surname>Suh</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Yoon</surname>
                <given-names>YE</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Youn</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Cho</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>YS</given-names>
              </name>
            </person-group>
            <article-title>Eosinophilic myocarditis: case series and literature review.</article-title>
            <source>Asia Pac Allergy</source>
            <year>2015</year>
            <month>Apr</month>
            <volume>5</volume>
            <issue>2</issue>
            <fpage>123</fpage>
            <page-range>123-7</page-range>
            <pub-id pub-id-type="pmid">25938077</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25469.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lieberman</surname>
                <given-names>EB</given-names>
              </name>
              <name>
                <surname>Hutchins</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Herskowitz</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rose</surname>
                <given-names>NR</given-names>
              </name>
              <name>
                <surname>Baughman</surname>
                <given-names>KL</given-names>
              </name>
            </person-group>
            <article-title>Clinicopathologic description of myocarditis.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>1991</year>
            <month>Dec</month>
            <volume>18</volume>
            <issue>7</issue>
            <fpage>1617</fpage>
            <page-range>1617-26</page-range>
            <pub-id pub-id-type="pmid">1960305</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25469.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Blauwet</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Cooper</surname>
                <given-names>LT</given-names>
              </name>
            </person-group>
            <article-title>Idiopathic giant cell myocarditis and cardiac sarcoidosis.</article-title>
            <source>Heart Fail Rev</source>
            <year>2013</year>
            <month>Nov</month>
            <volume>18</volume>
            <issue>6</issue>
            <fpage>733</fpage>
            <page-range>733-46</page-range>
            <pub-id pub-id-type="pmid">23111533</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25469.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yazaki</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Isobe</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hiramitsu</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Morimoto</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hiroe</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Omichi</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Nakano</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Saeki</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Izumi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Sekiguchi</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Comparison of clinical features and prognosis of cardiac sarcoidosis and idiopathic dilated cardiomyopathy.</article-title>
            <source>Am J Cardiol</source>
            <year>1998</year>
            <month>Aug</month>
            <day>15</day>
            <volume>82</volume>
            <issue>4</issue>
            <fpage>537</fpage>
            <page-range>537-40</page-range>
            <pub-id pub-id-type="pmid">9723651</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25469.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ukena</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Mahfoud</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Kindermann</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Kandolf</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kindermann</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>B&#x000f6;hm</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Prognostic electrocardiographic parameters in patients with suspected myocarditis.</article-title>
            <source>Eur J Heart Fail</source>
            <year>2011</year>
            <month>Apr</month>
            <volume>13</volume>
            <issue>4</issue>
            <fpage>398</fpage>
            <page-range>398-405</page-range>
            <pub-id pub-id-type="pmid">21239404</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25469.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Smith</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Ladenson</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Mason</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Jaffe</surname>
                <given-names>AS</given-names>
              </name>
            </person-group>
            <article-title>Elevations of cardiac troponin I associated with myocarditis. Experimental and clinical correlates.</article-title>
            <source>Circulation</source>
            <year>1997</year>
            <month>Jan</month>
            <day>07</day>
            <volume>95</volume>
            <issue>1</issue>
            <fpage>163</fpage>
            <page-range>163-8</page-range>
            <pub-id pub-id-type="pmid">8994432</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25469.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lauer</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Niederau</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>K&#x000fc;hl</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Schannwell</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Pauschinger</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Strauer</surname>
                <given-names>BE</given-names>
              </name>
              <name>
                <surname>Schultheiss</surname>
                <given-names>HP</given-names>
              </name>
            </person-group>
            <article-title>Cardiac troponin T in patients with clinically suspected myocarditis.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>1997</year>
            <month>Nov</month>
            <day>01</day>
            <volume>30</volume>
            <issue>5</issue>
            <fpage>1354</fpage>
            <page-range>1354-9</page-range>
            <pub-id pub-id-type="pmid">9350939</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25469.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pinamonti</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Alberti</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Cigalotto</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Dreas</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Salvi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Silvestri</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Camerini</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Echocardiographic findings in myocarditis.</article-title>
            <source>Am J Cardiol</source>
            <year>1988</year>
            <month>Aug</month>
            <day>01</day>
            <volume>62</volume>
            <issue>4</issue>
            <fpage>285</fpage>
            <page-range>285-91</page-range>
            <pub-id pub-id-type="pmid">3400607</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25469.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Felker</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Boehmer</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Hruban</surname>
                <given-names>RH</given-names>
              </name>
              <name>
                <surname>Hutchins</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Kasper</surname>
                <given-names>EK</given-names>
              </name>
              <name>
                <surname>Baughman</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Hare</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Echocardiographic findings in fulminant and acute myocarditis.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2000</year>
            <month>Jul</month>
            <volume>36</volume>
            <issue>1</issue>
            <fpage>227</fpage>
            <page-range>227-32</page-range>
            <pub-id pub-id-type="pmid">10898439</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25469.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mobini</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Staudt</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Felix</surname>
                <given-names>SB</given-names>
              </name>
              <name>
                <surname>Baumann</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Wallukat</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Deinum</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Svensson</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Hjalmarson</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Fu</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Hemodynamic improvement and removal of autoantibodies against beta1-adrenergic receptor by immunoadsorption therapy in dilated cardiomyopathy.</article-title>
            <source>J Autoimmun</source>
            <year>2003</year>
            <month>Jun</month>
            <volume>20</volume>
            <issue>4</issue>
            <fpage>345</fpage>
            <page-range>345-50</page-range>
            <pub-id pub-id-type="pmid">12791320</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25469.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fields</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Ossorio</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Roy</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Denny</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Varga</surname>
                <given-names>DW</given-names>
              </name>
            </person-group>
            <article-title>Thallium-201 scintigraphy in the diagnosis and management of myocardial sarcoidosis.</article-title>
            <source>South Med J</source>
            <year>1990</year>
            <month>Mar</month>
            <volume>83</volume>
            <issue>3</issue>
            <fpage>339</fpage>
            <page-range>339-42</page-range>
            <pub-id pub-id-type="pmid">2315784</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25469.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ohira</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Tsujino</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Yoshinaga</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>&#x000b9;&#x02078;F-Fluoro-2-deoxyglucose positron emission tomography in cardiac sarcoidosis.</article-title>
            <source>Eur J Nucl Med Mol Imaging</source>
            <year>2011</year>
            <month>Sep</month>
            <volume>38</volume>
            <issue>9</issue>
            <fpage>1773</fpage>
            <page-range>1773-83</page-range>
            <pub-id pub-id-type="pmid">21559980</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25469.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Friedrich</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Sechtem</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Schulz-Menger</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Holmvang</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Alakija</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Cooper</surname>
                <given-names>LT</given-names>
              </name>
              <name>
                <surname>White</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Abdel-Aty</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Gutberlet</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Prasad</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Aletras</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Laissy</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Paterson</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Filipchuk</surname>
                <given-names>NG</given-names>
              </name>
              <name>
                <surname>Kumar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Pauschinger</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>P</given-names>
              </name>
              <collab>International Consensus Group on Cardiovascular Magnetic Resonance in Myocarditis</collab>
            </person-group>
            <article-title>Cardiovascular magnetic resonance in myocarditis: A JACC White Paper.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2009</year>
            <month>Apr</month>
            <day>28</day>
            <volume>53</volume>
            <issue>17</issue>
            <fpage>1475</fpage>
            <page-range>1475-87</page-range>
            <pub-id pub-id-type="pmid">19389557</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25469.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mirabel</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Luyt</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Leprince</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Trouillet</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>L&#x000e9;ger</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Pavie</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chastre</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Combes</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Outcomes, long-term quality of life, and psychologic assessment of fulminant myocarditis patients rescued by mechanical circulatory support.</article-title>
            <source>Crit Care Med</source>
            <year>2011</year>
            <month>May</month>
            <volume>39</volume>
            <issue>5</issue>
            <fpage>1029</fpage>
            <page-range>1029-35</page-range>
            <pub-id pub-id-type="pmid">21336134</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25469.r52">
          <label>52</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chen</surname>
                <given-names>YS</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Chou</surname>
                <given-names>NK</given-names>
              </name>
              <name>
                <surname>Han</surname>
                <given-names>YY</given-names>
              </name>
              <name>
                <surname>Chiu</surname>
                <given-names>IS</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>FY</given-names>
              </name>
              <name>
                <surname>Chu</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Ko</surname>
                <given-names>WJ</given-names>
              </name>
            </person-group>
            <article-title>Rescue for acute myocarditis with shock by extracorporeal membrane oxygenation.</article-title>
            <source>Ann Thorac Surg</source>
            <year>1999</year>
            <month>Dec</month>
            <volume>68</volume>
            <issue>6</issue>
            <fpage>2220</fpage>
            <page-range>2220-4</page-range>
            <pub-id pub-id-type="pmid">10617006</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25469.r53">
          <label>53</label>
          <element-citation publication-type="journal">
            <person-group>
              <collab>WRITING COMMITTEE MEMBERS</collab>
              <name>
                <surname>Yancy</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>Jessup</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bozkurt</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Butler</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Casey</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Colvin</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Drazner</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Filippatos</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Fonarow</surname>
                <given-names>GC</given-names>
              </name>
              <name>
                <surname>Givertz</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Hollenberg</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Lindenfeld</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Masoudi</surname>
                <given-names>FA</given-names>
              </name>
              <name>
                <surname>McBride</surname>
                <given-names>PE</given-names>
              </name>
              <name>
                <surname>Peterson</surname>
                <given-names>PN</given-names>
              </name>
              <name>
                <surname>Stevenson</surname>
                <given-names>LW</given-names>
              </name>
              <name>
                <surname>Westlake</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America.</article-title>
            <source>Circulation</source>
            <year>2016</year>
            <month>Sep</month>
            <day>27</day>
            <volume>134</volume>
            <issue>13</issue>
            <fpage>e282</fpage>
            <page-range>e282-93</page-range>
            <pub-id pub-id-type="pmid">27208050</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25469.r54">
          <label>54</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Al-Khatib</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Stevenson</surname>
                <given-names>WG</given-names>
              </name>
              <name>
                <surname>Ackerman</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Bryant</surname>
                <given-names>WJ</given-names>
              </name>
              <name>
                <surname>Callans</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Curtis</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Deal</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Dickfeld</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Field</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Fonarow</surname>
                <given-names>GC</given-names>
              </name>
              <name>
                <surname>Gillis</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Granger</surname>
                <given-names>CB</given-names>
              </name>
              <name>
                <surname>Hammill</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Hlatky</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Joglar</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Kay</surname>
                <given-names>GN</given-names>
              </name>
              <name>
                <surname>Matlock</surname>
                <given-names>DD</given-names>
              </name>
              <name>
                <surname>Myerburg</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Page</surname>
                <given-names>RL</given-names>
              </name>
            </person-group>
            <article-title>2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: Executive summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.</article-title>
            <source>Heart Rhythm</source>
            <year>2018</year>
            <month>Oct</month>
            <volume>15</volume>
            <issue>10</issue>
            <fpage>e190</fpage>
            <page-range>e190-e252</page-range>
            <pub-id pub-id-type="pmid">29097320</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25469.r55">
          <label>55</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Prochnau</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Surber</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kuehnert</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Heinke</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Klein</surname>
                <given-names>HU</given-names>
              </name>
              <name>
                <surname>Figulla</surname>
                <given-names>HR</given-names>
              </name>
            </person-group>
            <article-title>Successful use of a wearable cardioverter-defibrillator in myocarditis with normal ejection fraction.</article-title>
            <source>Clin Res Cardiol</source>
            <year>2010</year>
            <month>Feb</month>
            <volume>99</volume>
            <issue>2</issue>
            <fpage>129</fpage>
            <page-range>129-31</page-range>
            <pub-id pub-id-type="pmid">19921297</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25469.r56">
          <label>56</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Frustaci</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Russo</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Chimenti</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study.</article-title>
            <source>Eur Heart J</source>
            <year>2009</year>
            <month>Aug</month>
            <volume>30</volume>
            <issue>16</issue>
            <fpage>1995</fpage>
            <page-range>1995-2002</page-range>
            <pub-id pub-id-type="pmid">19556262</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25469.r57">
          <label>57</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kandolin</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Lehtonen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Salmenkivi</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>R&#x000e4;is&#x000e4;nen-Sokolowski</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lommi</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kupari</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis, treatment, and outcome of giant-cell myocarditis in the era of combined immunosuppression.</article-title>
            <source>Circ Heart Fail</source>
            <year>2013</year>
            <month>Jan</month>
            <volume>6</volume>
            <issue>1</issue>
            <fpage>15</fpage>
            <page-range>15-22</page-range>
            <pub-id pub-id-type="pmid">23149495</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25469.r58">
          <label>58</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Scott</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Ratliff</surname>
                <given-names>NB</given-names>
              </name>
              <name>
                <surname>Starling</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Young</surname>
                <given-names>JB</given-names>
              </name>
            </person-group>
            <article-title>Recurrence of giant cell myocarditis in cardiac allograft.</article-title>
            <source>J Heart Lung Transplant</source>
            <year>2001</year>
            <month>Mar</month>
            <volume>20</volume>
            <issue>3</issue>
            <fpage>375</fpage>
            <page-range>375-80</page-range>
            <pub-id pub-id-type="pmid">11257566</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25469.r59">
          <label>59</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gullestad</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Aass</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Fjeld</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Wikeby</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Andreassen</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Ihlen</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Simonsen</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kjekshus</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Nitter-Hauge</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ueland</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Lien</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Fr&#x000f8;land</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Aukrust</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Immunomodulating therapy with intravenous immunoglobulin in patients with chronic heart failure.</article-title>
            <source>Circulation</source>
            <year>2001</year>
            <month>Jan</month>
            <day>16</day>
            <volume>103</volume>
            <issue>2</issue>
            <fpage>220</fpage>
            <page-range>220-5</page-range>
            <pub-id pub-id-type="pmid">11208680</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25469.r60">
          <label>60</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Malkiel</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kuan</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Diamond</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Autoimmunity in heart disease: mechanisms and genetic susceptibility.</article-title>
            <source>Mol Med Today</source>
            <year>1996</year>
            <month>Aug</month>
            <volume>2</volume>
            <issue>8</issue>
            <fpage>336</fpage>
            <page-range>336-42</page-range>
            <pub-id pub-id-type="pmid">8796919</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25469.r61">
          <label>61</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Basso</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Carturan</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Corrado</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Thiene</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Myocarditis and dilated cardiomyopathy in athletes: diagnosis, management, and recommendations for sport activity.</article-title>
            <source>Cardiol Clin</source>
            <year>2007</year>
            <month>Aug</month>
            <volume>25</volume>
            <issue>3</issue>
            <fpage>423</fpage>
            <page-range>423-9, vi</page-range>
            <pub-id pub-id-type="pmid">17961796</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25469.r62">
          <label>62</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pieroni</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Dello Russo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Marzo</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Pelargonio</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Casella</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bellocci</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Crea</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>High prevalence of myocarditis mimicking arrhythmogenic right ventricular cardiomyopathy differential diagnosis by electroanatomic mapping-guided endomyocardial biopsy.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2009</year>
            <month>Feb</month>
            <day>24</day>
            <volume>53</volume>
            <issue>8</issue>
            <fpage>681</fpage>
            <page-range>681-9</page-range>
            <pub-id pub-id-type="pmid">19232901</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25469.r63">
          <label>63</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chimenti</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Pieroni</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Maseri</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Frustaci</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Histologic findings in patients with clinical and instrumental diagnosis of sporadic arrhythmogenic right ventricular dysplasia.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2004</year>
            <month>Jun</month>
            <day>16</day>
            <volume>43</volume>
            <issue>12</issue>
            <fpage>2305</fpage>
            <page-range>2305-13</page-range>
            <pub-id pub-id-type="pmid">15193698</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25469.r64">
          <label>64</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hare</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Baughman</surname>
                <given-names>KL</given-names>
              </name>
            </person-group>
            <article-title>Fulminant and acute lymphocytic myocarditis: the prognostic value of clinicopathological classification.</article-title>
            <source>Eur Heart J</source>
            <year>2001</year>
            <month>Feb</month>
            <volume>22</volume>
            <issue>4</issue>
            <fpage>269</fpage>
            <page-range>269-70</page-range>
            <pub-id pub-id-type="pmid">11161940</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25469.r65">
          <label>65</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McCarthy</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Boehmer</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Hruban</surname>
                <given-names>RH</given-names>
              </name>
              <name>
                <surname>Hutchins</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Kasper</surname>
                <given-names>EK</given-names>
              </name>
              <name>
                <surname>Hare</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Baughman</surname>
                <given-names>KL</given-names>
              </name>
            </person-group>
            <article-title>Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis.</article-title>
            <source>N Engl J Med</source>
            <year>2000</year>
            <month>Mar</month>
            <day>09</day>
            <volume>342</volume>
            <issue>10</issue>
            <fpage>690</fpage>
            <page-range>690-5</page-range>
            <pub-id pub-id-type="pmid">10706898</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25469.r66">
          <label>66</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Caforio</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Calabrese</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Angelini</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tona</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Vinci</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bottaro</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ramondo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Carturan</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Iliceto</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Thiene</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Daliento</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and aetiopathogenetic features at diagnosis.</article-title>
            <source>Eur Heart J</source>
            <year>2007</year>
            <month>Jun</month>
            <volume>28</volume>
            <issue>11</issue>
            <fpage>1326</fpage>
            <page-range>1326-33</page-range>
            <pub-id pub-id-type="pmid">17493945</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25469.r67">
          <label>67</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cooper</surname>
                <given-names>LT</given-names>
              </name>
              <name>
                <surname>Zehr</surname>
                <given-names>KJ</given-names>
              </name>
            </person-group>
            <article-title>Biventricular assist device placement and immunosuppression as therapy for necrotizing eosinophilic myocarditis.</article-title>
            <source>Nat Clin Pract Cardiovasc Med</source>
            <year>2005</year>
            <month>Oct</month>
            <volume>2</volume>
            <issue>10</issue>
            <fpage>544</fpage>
            <page-range>544-8</page-range>
            <pub-id pub-id-type="pmid">16186853</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25469.r68">
          <label>68</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mendes</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Dec</surname>
                <given-names>GW</given-names>
              </name>
              <name>
                <surname>Picard</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Palacios</surname>
                <given-names>IF</given-names>
              </name>
              <name>
                <surname>Newell</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Davidoff</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Right ventricular dysfunction: an independent predictor of adverse outcome in patients with myocarditis.</article-title>
            <source>Am Heart J</source>
            <year>1994</year>
            <month>Aug</month>
            <volume>128</volume>
            <issue>2</issue>
            <fpage>301</fpage>
            <page-range>301-7</page-range>
            <pub-id pub-id-type="pmid">8037097</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25469.r69">
          <label>69</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rahman</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Helou</surname>
                <given-names>EF</given-names>
              </name>
              <name>
                <surname>Gelzer-Bell</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Thompson</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Kuo</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Rodriguez</surname>
                <given-names>ER</given-names>
              </name>
              <name>
                <surname>Hare</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Baughman</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Kasper</surname>
                <given-names>EK</given-names>
              </name>
            </person-group>
            <article-title>Noninvasive diagnosis of biopsy-proven cardiac amyloidosis.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2004</year>
            <month>Feb</month>
            <day>04</day>
            <volume>43</volume>
            <issue>3</issue>
            <fpage>410</fpage>
            <page-range>410-5</page-range>
            <pub-id pub-id-type="pmid">15013123</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25469.r70">
          <label>70</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Frustaci</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Verardo</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Caldarulo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Acconcia</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Russo</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Chimenti</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Myocarditis in hypertrophic cardiomyopathy patients presenting acute clinical deterioration.</article-title>
            <source>Eur Heart J</source>
            <year>2007</year>
            <month>Mar</month>
            <volume>28</volume>
            <issue>6</issue>
            <fpage>733</fpage>
            <page-range>733-40</page-range>
            <pub-id pub-id-type="pmid">17309901</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25469.r71">
          <label>71</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fuse</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kodama</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Okura</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Ito</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hirono</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kato</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Hanawa</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Aizawa</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Predictors of disease course in patients with acute myocarditis.</article-title>
            <source>Circulation</source>
            <year>2000</year>
            <month>Dec</month>
            <day>05</day>
            <volume>102</volume>
            <issue>23</issue>
            <fpage>2829</fpage>
            <page-range>2829-35</page-range>
            <pub-id pub-id-type="pmid">11104740</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25469.r72">
          <label>72</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Felker</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Hu</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Hare</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Hruban</surname>
                <given-names>RH</given-names>
              </name>
              <name>
                <surname>Baughman</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Kasper</surname>
                <given-names>EK</given-names>
              </name>
            </person-group>
            <article-title>The spectrum of dilated cardiomyopathy. The Johns Hopkins experience with 1,278 patients.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>1999</year>
            <month>Jul</month>
            <volume>78</volume>
            <issue>4</issue>
            <fpage>270</fpage>
            <page-range>270-83</page-range>
            <pub-id pub-id-type="pmid">10424207</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25469.r73">
          <label>73</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bhasin</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Gupta</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Arava</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kothari</surname>
                <given-names>SS</given-names>
              </name>
            </person-group>
            <article-title>Eosinophilia to endomyocardial fibrosis: Documentation of a case.</article-title>
            <source>Ann Pediatr Cardiol</source>
            <year>2018</year>
            <season>May-Aug</season>
            <volume>11</volume>
            <issue>2</issue>
            <fpage>207</fpage>
            <page-range>207-210</page-range>
            <pub-id pub-id-type="pmid">29922022</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
